Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma

被引：0
|
作者：
Comoli, P
Pedrazzoli, P
Nocera, A
Labirio, M
Del Galdo, F
Basso, S
Schiavo, R
Tagliamacco, A
Carminati, O
De Palma, R
Siena, S
Locatelli, F
Maccario, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P709
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [11] Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma
    Gandhi, MK
    Lambley, E
    Burrows, J
    Dua, U
    Elliott, S
    Shaw, PJ
    Prince, HM
    Wolf, M
    Clarke, K
    Underhill, C
    Mills, T
    Mollee, P
    Gill, D
    Marlton, P
    Seymour, JF
    Khanna, R
    CLINICAL CANCER RESEARCH, 2006, 12 (02) : 460 - 464
  • [12] EPSTEIN-BARR VIRUS (EBV), LYMPHOCYTES AND TRANSFORMATION
    ZEUTHEN, J
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 (01) : 1 - 11
  • [13] Long Term Clinical Outcome of Treating PTLD Patients with Epstein-Barr Virus (EBV)-Specific Cytotoxic T Cells (CTL)
    Haque, T.
    McAulay, K. A.
    Kelly, D.
    Crawford, D. H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 137 - 137
  • [14] Cell therapy with EBV-specific cytotoxic T-lymphocytes for patients with nasopharingeal carcinoma
    Comoli, P.
    Secondino, S.
    Licitra, L. F.
    Schiavo, R.
    Schiavetto, I.
    Gurrado, A.
    Locati, L.
    Pedrazzoli, P.
    Locatelli, F.
    Siena, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [15] Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria
    Habeeb, Rana
    al Hafar, Lina
    Monem, Fawza
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2021, 15 (12): : 1917 - 1922
  • [16] Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease
    Roskrow, MA
    Rooney, CM
    Heslop, HE
    Brenner, MK
    Krance, RA
    Gresik, MV
    McClain, K
    Aguilar, LK
    Grilley, B
    Rob, E
    Carrum, G
    HUMAN GENE THERAPY, 1998, 9 (08) : 1237 - 1250
  • [17] THE NASOPHARYNGEAL CARCINOMA AND EPSTEIN-BARR VIRUS (EBV) SPECIFIC IGA
    DESGRANGES, C
    PATHOLOGIE BIOLOGIE, 1981, 29 (10): : 587 - 589
  • [18] Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes
    Pepperl, S
    Benninger-Döring, G
    Modrow, S
    Wolf, H
    Jilg, W
    JOURNAL OF VIROLOGY, 1998, 72 (11) : 8644 - 8649
  • [19] Syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma
    Kanegane, H
    Bhatia, K
    Gutierrez, M
    Kaneda, H
    Wada, T
    Yachie, A
    Seki, H
    Arai, T
    Kagimoto, S
    Okazaki, M
    Oh-ishi, T
    Moghaddam, A
    Wang, F
    Tosato, G
    BLOOD, 1998, 91 (06) : 2085 - 2091
  • [20] Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma
    Levin, Lynn I.
    Chang, Ellen T.
    Ambinder, Richard F.
    Lennette, Evelyne T.
    Rubertone, Mark V.
    Mann, Risa B.
    Borowitz, Michael
    Weir, Edward G.
    Abbondanzo, Susan L.
    Mueller, Nancy E.
    BLOOD, 2012, 120 (18) : 3750 - 3755
12345